Hematopoietic growth factors in breast cancer — Overview C. Kent Osborne Minisymposium Pages: S1 - S2
Preclinical studies and future directions in the development of new hematologic growth factors Steven Gillis Minisymposium Pages: S3 - S9
Dose intensity as a therapeutic strategy in breast cancer C. Kent Osborne Minisymposium Pages: S11 - S14
Dose-intensive treatment of breast cancer supported by granulocyte-macrophage colony-stimulating factor (GM-CSF) James A. Neidhart Minisymposium Pages: S15 - S23
GM-CSF potentiated peripheral blood progenitor cell (PBPC) collection with or without bone marrow as hematologic support of high-dose chemotherapy: Two protocols Anthony D. EliasRosemary MazanetKaren Antman Minisymposium Pages: S25 - S29